This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| SARS | 1371 |
| COVID-19 | 1298 |
| CoV-2 | 975 |
| China | 551 |
| MERS | 493 |
| J | 472 |
| Hajj | 438 |
| CoV | 398 |
| Health | 354 |
| Wuhan | 318 |
| PCR | 259 |
| Coronavirus | 225 |
| Africa | 204 |
| Korea | 203 |
| East | 196 |
| Middle | 183 |
| March | 179 |
| Disease | 178 |
| RT | 174 |
| Ebola | 172 |
| South | 171 |
| RNA | 168 |
| HIV | 159 |
| World | 153 |
| Dis | 151 |
| Int | 150 |
| Table | 143 |
| January | 139 |
| February | 139 |
| Saudi | 133 |
| Organization | 130 |
| H1N1 | 125 |
| Kawasaki | 122 |
| ICU | 122 |
| April | 116 |
| A | 116 |
| Arabia | 115 |
| Hubei | 109 |
| Rt | 108 |
| sha | 105 |
| RSV | 105 |
| Hospital | 104 |
| S. | 98 |
| CT | 98 |
| CI | 95 |
| May | 93 |
| H5N1 | 93 |
| TCZ | 92 |
| Kong | 91 |
| EV71 | 91 |
| KD | 90 |
| Hong | 90 |
| University | 87 |
| Novaferon | 86 |
| tocilizumab | 84 |
| Novel | 84 |
| Taiwan | 82 |
| WHO | 80 |
| Italy | 79 |
| Japan | 75 |
| Control | 75 |
| ARDS | 75 |
| International | 74 |
| United | 74 |
| Province | 73 |
| National | 72 |
| HCQ | 72 |
| December | 71 |
| USA | 70 |
| US | 69 |
| Influenza | 69 |
| T | 68 |
| C | 66 |
| IL-6 | 65 |
| IV | 64 |
| CRP | 64 |
| Asia | 64 |
| IgM | 63 |
| Wang | 61 |
| Ministry | 59 |
| Clinical | 59 |
| anakinra | 58 |
| CDC | 57 |
| June | 57 |
| New | 56 |
| Covid-19 | 56 |
| Infectious | 56 |
| mg | 55 |
| LPV | 55 |
| Research | 54 |
| Prevention | 54 |
| IgG | 54 |
| Group | 54 |
| Syndrome | 53 |
| States | 53 |
| Respiratory | 53 |
| Pneumonia | 53 |
| Medical | 53 |
| ACE2 | 53 |
| Singapore | 53 |
| West | 51 |
| Lopinavir | 50 |
| B | 50 |
| Beijing | 49 |
| Diseases | 49 |
| Republic | 49 |
| Patients | 48 |
| Ritonavir | 47 |
| MRSA | 47 |
| D | 47 |
| TPE | 46 |
| Staphylococcus | 45 |
| Al | 45 |
| APN | 44 |
| 44 | |
| PPE | 44 |
| Tocilizumab | 44 |
| qPCR | 44 |
| OD | 43 |
| CD4 | 43 |
| Marburg | 42 |
| GD | 42 |
| Committee | 42 |
| Global | 41 |
| Seoul | 41 |
| Transmission | 41 |
| meta | 41 |
| Li | 40 |
| IQR | 40 |
| EVD | 40 |
| Treatment | 40 |
| Chinese | 39 |
| Chen | 39 |
| COVID19-CS | 39 |
| Abstract | 39 |
| Society | 38 |
| Xu | 38 |
| Virus | 38 |
| Wu | 37 |
| MCAS | 37 |
| Center | 37 |
| Association | 37 |
| Europe | 36 |
| Framework | 36 |
| HLA | 36 |
| July | 36 |
| Zhang | 36 |
| PSI | 36 |
| September | 35 |
| Germany | 35 |
| L | 34 |
| Analysis | 34 |
| City | 34 |
| Emergency | 34 |
| Oman | 34 |
| Study | 34 |
| lymphopenia | 34 |
| Zhou | 33 |
| SC | 33 |
| Medicine | 33 |
| KCDC | 32 |
| ARI | 32 |
| Guinea | 32 |
| Human | 32 |
| Risk | 32 |
| Mecca | 32 |
| Science | 32 |
| Trends | 32 |
| IRT | 31 |
| August | 31 |
| COVID | 31 |
| America | 31 |
| Infection | 31 |
| Leone | 31 |
| Sierra | 31 |
| France | 30 |
| Fig | 30 |
| Brazil | 30 |
| UK | 29 |
| Chi | 29 |
| CP | 29 |
| SP | 28 |
| Daegu | 28 |
| KSA | 28 |
| Sendai | 28 |
| Supplementary | 28 |
| neurosensory | 28 |
| York | 27 |
| MSC | 27 |
| Lancet | 27 |
| Figure | 27 |
| Epidemiology | 27 |
| Data | 27 |
| Cov-2 | 27 |
| Kingdom | 26 |
| CoV. | 26 |
| ESC | 26 |
| Thailand | 26 |
| Public | 26 |
| Report | 26 |
| TB | 26 |
| Liberia | 25 |
| Centers | 25 |
| General | 25 |
| Hydroxychloroquine | 25 |
| CD8 | 25 |
| N | 25 |
| Review | 25 |
| Umrah | 25 |
| Pandemic | 25 |
| Huang | 24 |
| Flu | 24 |
| CAP | 24 |
| Australia | 24 |
| Viral | 23 |
| SPSS | 23 |
| Lin | 23 |
| Institute | 23 |
| Dr. | 23 |
| Southeast | 22 |
| Feb | 22 |
| Haiti | 22 |
| Yu | 22 |
| U | 22 |
| VP1 | 22 |
| parainfluenza | 22 |
| M. | 21 |
| Bangladesh | 21 |
| Centre | 21 |
| European | 21 |
| F | 21 |
| IHR | 21 |
| Iran | 21 |
| Lee | 21 |
| Liu | 21 |
| doc_id | 21 |
| NCPP | 21 |
| Vietnam | 21 |
| WBC | 21 |
| Yang | 21 |
| hs | 21 |
| nafamostat | 21 |
| ritonavir | 21 |
| R0 | 21 |
| Administration | 20 |
| Detection | 20 |
| Characteristics | 20 |
| B. | 20 |
| Government | 20 |
| AUC | 20 |
| AIDS | 20 |
| < | 20 |
| Ethics | 20 |
| Zumla | 20 |
| HBoV | 20 |
| Outbreak | 20 |
| nan | 20 |
| People | 20 |
| 20 | |
| IDU | 20 |
| North | 20 |
| Inc. | 20 |
| Laboratory | 20 |
| Mass | 19 |
| African | 19 |
| Care | 19 |
| Commission | 19 |
| Congo | 19 |
| Diamond | 19 |
| Games | 19 |
| Makkah | 19 |
| Guangzhou | 19 |
| October | 19 |
| Princess | 19 |
| Trial | 19 |
| Uganda | 19 |
| Zhejiang | 19 |
| Zika | 19 |
| st | 19 |
| Memish | 19 |
| Infections | 18 |
| Children | 18 |
| Evaluation | 18 |
| FDA | 18 |
| Fisher | 18 |
| Gyeonggi | 18 |
| ILI | 18 |
| Impact | 18 |
| Isolation | 18 |
| NPI | 18 |
| Poisson | 18 |
| S | 18 |
| Technology | 18 |
| hydroxychloroquine | 18 |
| novaPDF | 18 |
| Management | 18 |
| Central | 17 |
| DIC | 17 |
| Community | 17 |
| Chan | 17 |
| Bhutan | 17 |
| Case | 17 |
| CURB-65 | 17 |
| CFR | 17 |
| AE | 17 |
| Development | 17 |
| Hospitalized | 17 |
| India | 17 |
| Tokyo | 17 |
| Model | 17 |
| Zambia | 17 |
| Use | 17 |
| Zhao | 17 |
| System | 17 |
| Saharan | 17 |
| SRT | 17 |
| Response | 17 |
| LOS | 16 |
| Australian | 16 |
| C. | 16 |
| COPD | 16 |
| Ct | 16 |
| Food | 16 |
| Foundation | 16 |
| Geneva | 16 |
| Severe | 16 |
| MCs | 16 |
| PIR | 16 |
| PIV | 16 |
| Regulations | 16 |
| Zhu | 16 |
| TM | 16 |
| Netherlands | 16 |
| First | 15 |
| Kim | 15 |
| J. | 15 |
| IP | 15 |
| II | 15 |
| H. | 15 |
| Chowell | 15 |
| Drug | 15 |
| Department | 15 |
| MHC | 15 |
| CXR | 15 |
| CA | 15 |
| Lu | 15 |
| LRT | 15 |
| Network | 15 |
| Southern | 15 |
| remdesivir | 15 |
| oseltamivir | 15 |
| PPV | 15 |
| hypogeusia | 15 |
| TNF | 15 |
| Sun | 15 |
| neutrophilia | 15 |
| Seroprevalence | 15 |
| S1 | 15 |
| R | 15 |
| Petersen | 15 |
| Pearson | 15 |
| Moran | 14 |
| COV-2 | 14 |
| Egypt | 14 |
| Emerging | 14 |
| England | 14 |
| HCP | 14 |
| HCoV | 14 |
| IMV | 14 |
| Lai | 14 |
| Malaysia | 14 |
| Mann | 14 |
| interleukin-6 | 14 |
| Nations | 14 |
| aOR | 14 |
| Rapid | 14 |
| square | 14 |
| azithromycin | 14 |
| disease | 14 |
| Vero | 14 |
| TOH | 14 |
| Surveillance | 14 |
| Spain | 14 |
| Disaster | 13 |
| King | 13 |
| Histoplasma | 13 |
| HCWs | 13 |
| Fund | 13 |
| Favipiravir | 13 |
| E6 | 13 |
| Ahmed | 13 |
| DRR | 13 |
| Chest | 13 |
| California | 13 |
| Board | 13 |
| AQI | 13 |
| NP | 13 |
| NK | 13 |
| IL-10 | 13 |
| NPV | 13 |
| RTI | 13 |
| Nishiura | 13 |
| lopinavir | 13 |
| Whitney | 13 |
| VHF | 13 |
| Time | 13 |
| State | 13 |
| UN | 13 |
| Professor | 13 |
| Population | 13 |
| Pan | 13 |
| Pakistan | 13 |
| P. | 13 |
| mid | 13 |
| College | 12 |
| Luo | 12 |
| Lombardy | 12 |
| Kit | 12 |
| Eskild | 12 |
| Early | 12 |
| Diagnosis | 12 |
| DNA | 12 |
| Applied | 12 |
| Choi | 12 |
| Cheng | 12 |
| Cao | 12 |
| COVID-2019 | 12 |
| Biosystems | 12 |
| Arshad | 12 |
| MOH | 12 |
| Air | 12 |
| Agency | 12 |
| Lymphopenia | 12 |
| Gyeongbuk | 12 |
| Mast | 12 |
| Riyadh | 12 |
| Medina | 12 |
| XiaoGan | 12 |
| URT | 12 |
| U.S. | 12 |
| Team | 12 |
| Streptococcus | 12 |
| ST | 12 |
| SI | 12 |
| Trang | 12 |
| Reduction | 12 |
| Outcomes | 12 |
| Omanis | 12 |
| November | 12 |
| Nipah | 12 |
| Nha | 12 |
| PM | 12 |
| NPW | 12 |
| Epidemiological | 11 |
| Declaration | 11 |
| Dynamics | 11 |
| E. | 11 |
| ELISA | 11 |
| HCoV-229E | 11 |
| Journal | 11 |
| H | 11 |
| Hunan | 11 |
| Co. | 11 |
| DAD | 11 |
| Alimuddin | 11 |
| Cell | 11 |
| CD3 | 11 |
| CD13 | 11 |
| CD10 | 11 |
| Blastomyces | 11 |
| Bank | 11 |
| Background | 11 |
| Asymptomatic | 11 |
| American | 11 |
| Adults | 11 |
| ACDC | 11 |
| IBM | 11 |
| GenBank | 11 |
| LBS | 11 |
| Safety | 11 |
| LUMIPULSE | 11 |
| α | 11 |
| Van | 11 |
| Union | 11 |
| Turkey | 11 |
| Thimphu | 11 |
| Therapy | 11 |
| T. | 11 |
| Survey | 11 |
| Shi | 11 |
| association | 11 |
| SD | 11 |
| Olympic | 11 |
| SAS | 11 |
| MC | 11 |
| Office | 11 |
| Olfactory | 11 |
| OC43 | 11 |
| One | 11 |
| Paul | 11 |
| Plasma | 11 |
| Project | 11 |
| Indonesia | 10 |
| Enterovirus | 10 |
| HR | 10 |
| HIV-1 | 10 |
| Guo | 10 |
| Guangdong | 10 |
| Gaza | 10 |
| Gao | 10 |
| FluA | 10 |
| Epidemic | 10 |
| Corona | 10 |
| ESCMID | 10 |
| Day | 10 |
| Council | 10 |
| Coronaviruses | 10 |
| CoV2 | 10 |
| Bats | 10 |
| Afrin | 10 |
| AST | 10 |
| Ltd. | 10 |
| LRTI | 10 |
| Hui | 10 |
| Madrid | 10 |
| SQT | 10 |
| MoH | 10 |
| ± | 10 |
| rd | 10 |
| rRT | 10 |
| Wong | 10 |
| TnI | 10 |
| Tang | 10 |
| Shanghai | 10 |
| Search | 10 |
| marneffei | 10 |
| Rio | 10 |
| R(t | 10 |
| Richards | 10 |
| Objectives | 10 |
| Park | 10 |
| • | 10 |
| Region | 10 |
| Remdesivir | 10 |
| ROC | 10 |
| CS | 9 |
| David | 9 |
| Canada | 9 |
| Cancer | 9 |
| Chlamydia | 9 |
| Cytokine | 9 |
| DRB1 | 9 |
| EC50 | 9 |
| Dr | 9 |
| GGO | 9 |
| Effect | 9 |
| Efficacy | 9 |
| Factors | 9 |
| Effectiveness | 9 |
| Assessment | 9 |
| CRF07_BC | 9 |
| CO | 9 |
| CMOS | 9 |
| CD45 | 9 |
| Botswana | 9 |
| Belgium | 9 |
| Azhar | 9 |
| Austria | 9 |
| Acute | 9 |
| AU | 9 |
| ADV | 9 |
| -p | 9 |
| Guan | 9 |
| GHSI | 9 |
| Protection | 9 |
| Guidelines | 9 |
| Policy | 9 |
| HAdV | 9 |
| virus | 9 |
| range | 9 |
| i | 9 |
| hepatitis | 9 |
| a2b | 9 |
| Tongji | 9 |
| Summary | 9 |
| Statistics | 9 |
| Shim | 9 |
| Sciences | 9 |
| Salmonella | 9 |
| RV | 9 |
| Washington | 9 |
| Parma | 9 |
| Investigation | 9 |
| ICUs | 9 |
| PLT | 9 |
| IL-1 | 9 |
| Incubation | 9 |
| Institutional | 9 |
| Index | 9 |
| Jeddah | 9 |
| K. | 9 |
| Meng | 9 |
| Mexico | 9 |
| Nigeria | 9 |
| Florida | 8 |
| IPC | 8 |
| French | 8 |
| G | 8 |
| H7N9 | 8 |
| HFMD | 8 |
| HMPV | 8 |
| III | 8 |
| Joint | 8 |
| Ill | 8 |
| Imaging | 8 |
| Infected | 8 |
| Jan | 8 |
| KPSC | 8 |
| Kapata | 8 |
| Epidemiologic | 8 |
| Expert | 8 |
| Ag | 8 |
| Distress | 8 |
| Associated | 8 |
| Liang | 8 |
| A. | 8 |
| Affiliated | 8 |
| Americans | 8 |
| Antigen | 8 |
| Arabian | 8 |
| Atahualpa | 8 |
| Diagnostics | 8 |
| Berlin | 8 |
| C.I. | 8 |
| CIM | 8 |
| Chloroquine | 8 |
| Company | 8 |
| D. | 8 |
| LDH | 8 |
| VTM | 8 |
| Load | 8 |
| Shenzhen | 8 |
| Pulmonary | 8 |
| Ruan | 8 |
| SIADH | 8 |
| SSP | 8 |
| School | 8 |
| Security | 8 |
| Shiraz | 8 |
| Patient | 8 |
| VTE | 8 |
| WHA | 8 |
| Wölfel | 8 |
| series | 8 |
| van | 8 |
| Ltd | 8 |
| PubMed | 8 |
| γ | 8 |
| Pacific | 8 |
| N95 | 8 |
| PHEIC | 8 |
| McCloskey | 8 |
| Mesenchymal | 8 |
| Mission | 8 |
| Mizumoto | 8 |
| Molecular | 8 |
| Meta | 8 |
| NPIs | 8 |
| Northern | 8 |
| O'Brien | 8 |
| OR | 8 |
| Oxford | 8 |
| NY | 8 |
| P1 | 8 |
| Features | 7 |
| Fu | 7 |
| Francesca | 7 |
| Fever | 7 |
| Feng | 7 |
| Esam | 7 |
| Fan | 7 |
| Excel | 7 |
| Equatorial | 7 |
| Gene | 7 |
| EpiEstim | 7 |
| GHSA | 7 |
| Hu | 7 |
| Granger | 7 |
| Guillain | 7 |
| Gulf | 7 |
| H274Y | 7 |
| HRCT | 7 |
| Healthcare | 7 |
| Helsinki | 7 |
| I | 7 |
| IFN | 7 |
| Illness | 7 |
| English | 7 |
| Environmental | 7 |
| Askarian | 7 |
| Elsevier | 7 |
| C956 | 7 |
| ALT | 7 |
| Adenovirus | 7 |
| Age | 7 |
| Ali | 7 |
| Anon | 7 |
| Antibody | 7 |
| Arab | 7 |
| Intensive | 7 |
| Bat | 7 |
| Biotech | 7 |
| Changsha | 7 |
| De | 7 |
| Church | 7 |
| CoV-1 | 7 |
| Cochrane | 7 |
| Colombia | 7 |
| Comparative | 7 |
| Comparison | 7 |
| Consortium | 7 |
| Convalescent | 7 |
| Cox | 7 |
| Cup | 7 |
| Incidence | 7 |
| Ghana | 7 |
| Interim | 7 |
| San | 7 |
| Service | 7 |
| Statistical | 7 |
| Sub | 7 |
| Switzerland | 7 |
| TMPRSS2 | 7 |
| Tariq | 7 |
| Toronto | 7 |
| VLP | 7 |
| W. | 7 |
| Yan | 7 |
| Yat | 7 |
| Young | 7 |
| Zou | 7 |
| administration | 7 |
| ageusia | 7 |
| genomic | 7 |
| medRxiv | 7 |
| min | 7 |
| multicentre | 7 |
| nd | 7 |
| recrudescence | 7 |
| sen | 7 |
| Interventions | 7 |
| Scientific | 7 |
| Yoshida | 7 |
| S2 | 7 |
| Myanmar | 7 |
| John | 7 |
| Rashid | 7 |
| Jun | 7 |
| L. | 7 |
| Latin | 7 |
| London | 7 |
| Lung | 7 |
| McGoogan | 7 |
| Microbiology | 7 |
| Muscat | 7 |
| M | 7 |
| OPV | 7 |
| Parainfluenza | 7 |
| N2 | 7 |
| Nafamostat | 7 |
| Neisseria | 7 |
| Program | 7 |
| Nile | 7 |
| OBJECTIVES | 7 |
| ORF1a | 7 |
| Osman | 7 |
| N. | 7 |
| Hunter | 6 |
| I. | 6 |
| HA | 6 |
| Huanan | 6 |
| ID | 6 |
| IL | 6 |
| Hung | 6 |
| HPIV3 | 6 |
| Havers | 6 |
| Hajjis | 6 |
| HRV | 6 |
| IRR | 6 |
| HLH | 6 |
| IL-2 | 6 |
| Malaria | 6 |
| Infodemiology | 6 |
| Israel | 6 |
| JAK | 6 |
| Janeiro | 6 |
| K | 6 |
| Kaplan | 6 |
| Kenya | 6 |
| Klebsiella | 6 |
| Likert | 6 |
| Ma | 6 |
| Mehta | 6 |
| Methicillin | 6 |
| Grant | 6 |
| Guidance | 6 |
| Abdulaziz | 6 |
| Fujirebio | 6 |
| Chiang | 6 |
| Molderings | 6 |
| ADH | 6 |
| AKI | 6 |
| APTT | 6 |
| Americas | 6 |
| Anakinra | 6 |
| Anderson | 6 |
| Assays | 6 |
| Barr | 6 |
| Bin | 6 |
| CD19 | 6 |
| CRS | 6 |
| Cohen | 6 |
| Estimation | 6 |
| Cohort | 6 |
| Concern | 6 |
| Contact | 6 |
| Crimean | 6 |
| DENV | 6 |
| DK | 6 |
| DMS | 6 |
| Dakaractu | 6 |
| Democratic | 6 |
| Diagnostic | 6 |
| ES | 6 |
| Epstein | 6 |
| Models | 6 |
| Song | 6 |
| NHIS | 6 |
| Test | 6 |
| Theoharides | 6 |
| Thompson | 6 |
| Tian | 6 |
| Toniati | 6 |
| Vaccines | 6 |
| Viruses | 6 |
| WCC | 6 |
| Wei | 6 |
| Xiao | 6 |
| Y | 6 |
| Year | 6 |
| Yezli | 6 |
| Ying | 6 |
| Zheng | 6 |
| Ziad | 6 |
| bp | 6 |
| bronchoalveolar | 6 |
| department | 6 |
| health | 6 |
| key | 6 |
| multiorgan | 6 |
| ng | 6 |
| sera | 6 |
| sharps | 6 |
| t. | 6 |
| Nowcasting | 6 |
| thrombi | 6 |
| Texas | 6 |
| favipiravir | 6 |
| Tanzania | 6 |
| Pseudomonas | 6 |
| PCT | 6 |
| Taizhou | 6 |
| Olympics | 6 |
| PE | 6 |
| PSM | 6 |
| PT | 6 |
| Peng | 6 |
| Peter | 6 |
| Platform | 6 |
| Pollán | 6 |
| Post | 6 |
| Predictors | 6 |
| Preparedness | 6 |
| Panel | 6 |
| Qiagen | 6 |
| RCT | 6 |
| Robert | 6 |
| Stringhini | 6 |
| Roche | 6 |
| Rossotti | 6 |
| Ruuskanen | 6 |
| Strategy | 6 |
| Social | 6 |
| Stem | 6 |
| R(2 | 6 |
| Systems | 6 |
| G20 | 5 |
| G. | 5 |
| Garcia | 5 |
| GISAID | 5 |
| Gaborone | 5 |
| Fruit | 5 |
| Gautret | 5 |
| GraphPad | 5 |
| Fukushima | 5 |
| FluB | 5 |
| Foster | 5 |
| Force | 5 |
| Florez | 5 |
| Ferguson | 5 |
| Epicontact | 5 |
| Education | 5 |
| Eastern | 5 |
| Hendra | 5 |
| Economic | 5 |
| Guaraldi | 5 |
| Jordan | 5 |
| Hiroyuki | 5 |
| Hlaing | 5 |
| Long | 5 |
| ENE | 5 |
| Lipsitch | 5 |
| Leptospira | 5 |
| Lag | 5 |
| LYAC | 5 |
| Kwok | 5 |
| Knowledge | 5 |
| K/µL | 5 |
| Ji | 5 |
| JDWNRH | 5 |
| Interleukin-6 | 5 |
| Information | 5 |
| IRB | 5 |
| IMED | 5 |
| IL-4 | 5 |
| Hsieh | 5 |
| Hopkins | 5 |
| Ho | 5 |
| EV | 5 |
| Brian | 5 |
| EMG | 5 |
| EMC | 5 |
| Candida | 5 |
| CSF | 5 |
| COVID19 | 5 |
| CNS | 5 |
| Based | 5 |
| Baidu | 5 |
| BLD | 5 |
| BACKGROUND | 5 |
| Assembly | 5 |
| Armonk | 5 |
| Area | 5 |
| Application | 5 |
| Alere | 5 |
| Advisory | 5 |
| Activation | 5 |
| Abdullah | 5 |
| ABI | 5 |
| 8) | 5 |
| MD | 5 |
| Chicago | 5 |
| Chikungunya | 5 |
| Chisquare | 5 |
| DR | 5 |
| EHR | 5 |
| EC | 5 |
| EBOV | 5 |
| Doremalen | 5 |
| Denmark | 5 |
| Dengue | 5 |
| Dar | 5 |
| Dahl | 5 |
| DQB1 | 5 |
| Chongqing | 5 |
| Corporation | 5 |
| Coronavirus-2 | 5 |
| Coronaviridae | 5 |
| Corman | 5 |
| Cori | 5 |
| Contacts | 5 |
| Consensus | 5 |
| Chu | 5 |
| MAS | 5 |
| Student | 5 |
| MG | 5 |
| Salje | 5 |
| Tropical | 5 |
| Traditional | 5 |
| Tianjin | 5 |
| Testing | 5 |
| Temporal | 5 |
| Tawfiq | 5 |
| Taqman | 5 |
| Tan | 5 |
| Talaromyces | 5 |
| Systematic | 5 |
| Sustainable | 5 |
| Station | 5 |
| Special | 5 |
| Somalia | 5 |
| Smith | 5 |
| Smell | 5 |
| Sichuan | 5 |
| Shen | 5 |
| Serial | 5 |
| URTI | 5 |
| UTR | 5 |
| Units | 5 |
| committee | 5 |
| Madariaga | 5 |
| ribavirin | 5 |
| qRT | 5 |
| protein | 5 |
| p<0.01 | 5 |
| monocyte | 5 |
| mmol | 5 |
| metapneumovirus | 5 |
| chemosensory | 5 |
| Wan | 5 |
| bocavirus | 5 |
| antibody | 5 |
| Zhuang | 5 |
| ZKV | 5 |
| Youth | 5 |
| Yong | 5 |
| Yi | 5 |
| Xie | 5 |
| Sanger | 5 |
| control | 5 |
| SSNHL | 5 |
| Mohamed | 5 |
| Neutrophil | 5 |
| Nasopharyngeal | 5 |
| Nanjing | 5 |
| NO(2 | 5 |
| NL63 | 5 |
| NGS | 5 |
| NCP | 5 |
| Mortality | 5 |
| Mina | 5 |
| Ng | 5 |
| Min | 5 |
| Methods | 5 |
| Matlab | 5 |
| Maria | 5 |
| Mao | 5 |
| Mandourah | 5 |
| SOT | 5 |
| Maeurer | 5 |
| News | 5 |
| Martin | 5 |
| Nguyen | 5 |
| Prof. | 5 |
| Objective | 5 |
| SAE | 5 |
| Rosenberg | 5 |
| Quarantine | 5 |
| Qin | 5 |
| Qian | 5 |
| Qatar | 5 |
| Pteropus | 5 |
| Rai | 5 |
| Preventive | 5 |
| Pathogen | 5 |
| Oral | 5 |
| PEF | 5 |
| PICU | 5 |
| Royal | 5 |
| Pattern | 5 |
| Period | 5 |
| Prediction | 5 |
| Household | 4 |
| Harunor | 4 |
| Genomic | 4 |
| Goals | 4 |
| Guide | 4 |
| Guideline | 4 |
| HSCRP | 4 |
| HW | 4 |
| Head | 4 |
| Genetic | 4 |
| Hogan | 4 |
| Holshue | 4 |
| Hua | 4 |
| Hospitals | 4 |
| Hou | 4 |
| Hosmer | 4 |
| Fangcang | 4 |
| GPs | 4 |
| GCC | 4 |
| Escherichia | 4 |
| IHME | 4 |
| Estimating | 4 |
| Etiology | 4 |
| F. | 4 |
| Facemasks | 4 |
| Facility | 4 |
| Fahad | 4 |
| Fang | 4 |
| Federal | 4 |
| Findings | 4 |
| Football | 4 |
| Forum | 4 |
| G978 | 4 |
| GC | 4 |
| Humans | 4 |
| Lemeshow | 4 |
| IL-6R | 4 |
| ITU | 4 |
| Leung | 4 |
| Lewnard | 4 |
| Ling | 4 |
| Lo | 4 |
| Low | 4 |
| Lower | 4 |
| Lupus | 4 |
| MARV | 4 |
| MDR | 4 |
| MERS- | 4 |
| MRI | 4 |
| MS | 4 |
| Marburgvirus | 4 |
| Markus | 4 |
| Emirates | 4 |
| Lessler | 4 |
| Legionella | 4 |
| Le | 4 |
| Ippolito | 4 |
| Immune | 4 |
| Immunity | 4 |
| Immunization | 4 |
| Innovation | 4 |
| Insurance | 4 |
| Internal | 4 |
| JTL | 4 |
| Laura | 4 |
| KAP | 4 |
| Khan | 4 |
| Kissler | 4 |
| Korean | 4 |
| Kumbh | 4 |
| Kurulu | 4 |
| Enterobacteriaceae | 4 |
| Bureh | 4 |
| Embase | 4 |
| Cardiac | 4 |
| BMA | 4 |
| Bacillus | 4 |
| Badawi | 4 |
| Barré | 4 |
| Bilim | 4 |
| BinaxNow | 4 |
| Biotechnology | 4 |
| Bombali | 4 |
| Booy | 4 |
| British | 4 |
| Bureau | 4 |
| Burgner | 4 |
| CHIKV | 4 |
| CLEIA | 4 |
| CORIST | 4 |
| Approval | 4 |
| Approach | 4 |
| Antonio | 4 |
| ARC | 4 |
| Massachusetts | 4 |
| -Preliminary | 4 |
| 3CD | 4 |
| 3D | 4 |
| 8mg | 4 |
| ANOVA | 4 |
| AT | 4 |
| Antimicrobial | 4 |
| Abbott | 4 |
| Abri | 4 |
| Aedes | 4 |
| Aerosol | 4 |
| Alcoba | 4 |
| Angola | 4 |
| Cambodia | 4 |
| Carlos | 4 |
| El | 4 |
| Carrier | 4 |
| DPC | 4 |
| DRV | 4 |
| Dec | 4 |
| Dexamethasone | 4 |
| Di | 4 |
| Dimer | 4 |
| Director | 4 |
| Dong | 4 |
| Dysfunction | 4 |
| Dysregulation | 4 |
| E | 4 |
| ECMO | 4 |
| EU | 4 |
| Editor | 4 |
| Eighth | 4 |
| Cross | 4 |
| Cronbach | 4 |
| Critically | 4 |
| ClinicalTrials.gov | 4 |
| Caucasians | 4 |
| Cavalli | 4 |
| Challenges | 4 |
| Charles | 4 |
| Cheonan | 4 |
| Chew | 4 |
| Co | 4 |
| Critical | 4 |
| Collaborative | 4 |
| Compliance | 4 |
| Computing | 4 |
| Copan | 4 |
| County | 4 |
| Covid | 4 |
| Martínez | 4 |
| Macau | 4 |
| Matthew | 4 |
| Volumes | 4 |
| Telegraph | 4 |
| Tha | 4 |
| Threats | 4 |
| Thromboembolism | 4 |
| Tianlong | 4 |
| Times | 4 |
| Treatments | 4 |
| UTM | 4 |
| Umra | 4 |
| Unit | 4 |
| Upper | 4 |
| V. | 4 |
| Vaccine | 4 |
| Venezuela | 4 |
| Vincent | 4 |
| Taxonomy | 4 |
| Taste | 4 |
| Task | 4 |
| Storm | 4 |
| Software | 4 |
| Sood | 4 |
| Spanish | 4 |
| Standard | 4 |
| Standards | 4 |
| Stata | 4 |
| Structure | 4 |
| Tao | 4 |
| Sultanate | 4 |
| Supplemental | 4 |
| Sydney | 4 |
| TAC | 4 |
| Tambyah | 4 |
| Tangail | 4 |
| Virology | 4 |
| Wee | 4 |
| Shirah | 4 |
| Weekly | 4 |
| imipenem | 4 |
| influenza | 4 |
| kg | 4 |
| mL | 4 |
| mRNA | 4 |
| pharyngalgia | 4 |
| vietnam | 4 |
| vivo | 4 |
| xs | 4 |
| | | 4 |
| À1 | 4 |
| À80 | 4 |
| − | 4 |
| | 4 |
| May. | 4 |
| hCoV | 4 |
| east | 4 |
| catarrhalis | 4 |
| Yamanashi | 4 |
| Welfare | 4 |
| Western | 4 |
| Wilcoxon | 4 |
| Working | 4 |
| Xia | 4 |
| Y. | 4 |
| Yar | 4 |
| bpm | 4 |
| Yellow | 4 |
| Yen | 4 |
| Yin | 4 |
| agent(s | 4 |
| and/ | 4 |
| anti | 4 |
| Sir | 4 |
| national | 4 |
| Shincheonji | 4 |
| Pediatric | 4 |
| Nord | 4 |
| Nov | 4 |
| Novartis | 4 |
| O. | 4 |
| ORF | 4 |
| Observational | 4 |
| Oct | 4 |
| P | 4 |
| P<0.001 | 4 |
| PCV | 4 |
| PM(2.5 | 4 |
| PRISM | 4 |
| Paper | 4 |
| Paris | 4 |
| Pasteur | 4 |
| Non | 4 |
| Ni | 4 |
| Neurologic | 4 |
| Mohd | 4 |
| Meier | 4 |
| Self | 4 |
| | 4 |
| Mela | 4 |
| Merck | 4 |
| Meyer | 4 |
| Mustafa | 4 |
| Natural | 4 |
| Mycobacterium | 4 |
| NB | 4 |
| NHS | 4 |
| NIH | 4 |
| NSW | 4 |
| Nathan | 4 |
| Patel | 4 |
| Milan | 4 |
| Peihua | 4 |
| Receptor | 4 |
| Registry | 4 |
| Reporting | 4 |
| Reports | 4 |
| Retrospective | 4 |
| Richard | 4 |
| Rose | 4 |
| Rudan | 4 |
| Ryoo | 4 |
| SARI | 4 |
| SARS- | 4 |
| Saad | 4 |
| Salpêtrière | 4 |
| Seif | 4 |
| Penicillium | 4 |
| Seattle | 4 |
| Recommendations | 4 |
| STATA | 4 |
| Randomized | 4 |
| Preliminary | 4 |
| Radiology | 4 |
| Pierre | 4 |
| Pfizer | 4 |
| Plasmodium | 4 |
| Peninsula | 4 |
| Potential | 4 |
| Pitié | 4 |
| Presymptomatic | 4 |
| Protein | 4 |
| R. | 4 |
| Prevalence | 4 |
| Qiu | 4 |
| Phylogenetic | 4 |
| Profile | 4 |
| Gates | 3 |
| Genome | 3 |
| Geographic | 3 |
| Geographical | 3 |
| Giuseppe | 3 |
| Glasgow | 3 |
| Gostin | 3 |
| García | 3 |
| Gould | 3 |
| Governorate | 3 |
| Grand | 3 |
| Greater | 3 |
| Giahyue | 3 |
| HPIV | 3 |
| H.C. | 3 |
| H2N2 | 3 |
| H3N2 | 3 |
| H5 | 3 |
| HB | 3 |
| HPIV1 | 3 |
| HSCT | 3 |
| Hakan | 3 |
| Hao | 3 |
| Hawaii | 3 |
| Hay | 3 |
| Hebei | 3 |
| Gabon | 3 |
| Hematologic | 3 |
| Henry | 3 |
| Gallian | 3 |
| Fernández | 3 |
| GSK | 3 |
| GLMM | 3 |
| EpiData | 3 |
| Heymann | 3 |
| Equine | 3 |
| Eric | 3 |
| Erikstrup | 3 |
| Ethical | 3 |
| Euroimmun | 3 |
| Exposure | 3 |
| FM | 3 |
| FN | 3 |
| Failure | 3 |
| Falsey | 3 |
| Family | 3 |
| Farge | 3 |
| Feldman | 3 |
| Female | 3 |
| Fig.1D | 3 |
| Filoviruses | 3 |
| Finals | 3 |
| Ford | 3 |
| Franche | 3 |
| Francine | 3 |
| Francisco | 3 |
| Frank | 3 |
| Frequency | 3 |
| Fundación | 3 |
| G987A | 3 |
| GAM | 3 |
| GIS | 3 |
| Hernandez | 3 |
| Jiangxi | 3 |
| High | 3 |
| Kai | 3 |
| Jigme | 3 |
| Jiménez | 3 |
| Jinan | 3 |
| Jinyintan | 3 |
| Johns | 3 |
| Johnson | 3 |
| Jonathan | 3 |
| Jordi | 3 |
| Jose | 3 |
| Jroundi | 3 |
| Jung | 3 |
| KAMC | 3 |
| KFGH | 3 |
| Kaiser | 3 |
| Jesus | 3 |
| Kang | 3 |
| Keith | 3 |
| Keyaerts | 3 |
| Khanh | 3 |
| Kilic | 3 |
| Klopfenstein | 3 |
| Kraft | 3 |
| LC | 3 |
| LFA | 3 |
| LLC | 3 |
| LMIC | 3 |
| LMY | 3 |
| Entry | 3 |
| Jiang | 3 |
| Jean | 3 |
| Hiroshi | 3 |
| Induced | 3 |
| Hoa | 3 |
| Host | 3 |
| IAV | 3 |
| ICD-10 | 3 |
| IFA | 3 |
| IL-17 | 3 |
| IL-8 | 3 |
| ISARIC | 3 |
| Identification | 3 |
| Immunogenicity | 3 |
| Immunology | 3 |
| Imperial | 3 |
| Inc | 3 |
| Initiative | 3 |
| Jartti | 3 |
| Inoue | 3 |
| Institut | 3 |
| Institutes | 3 |
| Intelligence | 3 |
| Interval | 3 |
| Invitrogen | 3 |
| Island | 3 |
| Iwasaki | 3 |
| J.C. | 3 |
| JAF | 3 |
| JED | 3 |
| Japanese | 3 |
| Jardani | 3 |
| Environment | 3 |
| CD3+T | 3 |
| Engineering | 3 |
| Emerg | 3 |
| Azithromycin | 3 |
| B.1.1 | 3 |
| BALF | 3 |
| BD | 3 |
| BGI | 3 |
| Barasheed | 3 |
| Barre | 3 |
| Baseline | 3 |
| Basic | 3 |
| Bates | 3 |
| Beau | 3 |
| Benjamin | 3 |
| Berry | 3 |
| Bi | 3 |
| Big | 3 |
| Blumberg | 3 |
| Box | 3 |
| Branche | 3 |
| Brescia | 3 |
| Brunei | 3 |
| CC50 | 3 |
| CCHF | 3 |
| Lammers | 3 |
| CD4+T | 3 |
| CF | 3 |
| CKMB | 3 |
| CMAP | 3 |
| CPAP | 3 |
| CRF | 3 |
| Awareness | 3 |
| Award | 3 |
| Avian | 3 |
| Alert | 3 |
| -Call | 3 |
| 3C | 3 |
| A(H1N1 | 3 |
| ADPC | 3 |
| AJ421875 | 3 |
| AMED | 3 |
| Abu | 3 |
| Access | 3 |
| Acinetobacter | 3 |
| Affairs | 3 |
| Agenda | 3 |
| Agrawal | 3 |
| Airport | 3 |
| Alessandro | 3 |
| Assiri | 3 |
| Algeria | 3 |
| Allen | 3 |
| Althaus | 3 |
| Althouse | 3 |
| Anhui | 3 |
| Ann | 3 |
| Anne | 3 |
| Anti | 3 |
| Antibodies | 3 |
| Arabi | 3 |
| Arbidol | 3 |
| Arora | 3 |
| Artibeus | 3 |
| Cameroon | 3 |
| Campus | 3 |
| Cardiovascular | 3 |
| Drugbank | 3 |
| Cycle | 3 |
| D.K. | 3 |
| DRB3 | 3 |
| Daihai | 3 |
| Dear | 3 |
| Definition | 3 |
| Del | 3 |
| Deng | 3 |
| Dhungana | 3 |
| Direct | 3 |
| Directorate | 3 |
| Donor | 3 |
| Dorji | 3 |
| Duan | 3 |
| Country | 3 |
| Díaz | 3 |
| EBP | 3 |
| ECDC | 3 |
| EID | 3 |
| ENT | 3 |
| EPA | 3 |
| ESR | 3 |
| ESRD | 3 |
| Ecology | 3 |
| Ecuador | 3 |
| Egger | 3 |
| Elachola | 3 |
| Elevated | 3 |
| Cristina | 3 |
| Countries | 3 |
| Carollia | 3 |
| Chiu | 3 |
| Causes | 3 |
| Cells | 3 |
| Chain | 3 |
| Championship | 3 |
| Chanda | 3 |
| Chang | 3 |
| Chao | 3 |
| Chauhan | 3 |
| Chelsea | 3 |
| Cheung | 3 |
| Chiara | 3 |
| Chief | 3 |
| Chinazzi | 3 |
| Chong | 3 |
| Count | 3 |
| Christianville | 3 |
| Chronic | 3 |
| Chung | 3 |
| Climate | 3 |
| Clinic | 3 |
| CoV-2-specific | 3 |
| Collaboration | 3 |
| Comorbidities | 3 |
| Comté | 3 |
| Cook | 3 |
| Corp. | 3 |
| Correlation | 3 |
| Costa | 3 |
| Lam | 3 |
| BigDye | 3 |
| Lao | 3 |
| Wales | 3 |
| Sutton | 3 |
| Syria | 3 |
| Systemic | 3 |
| Sánchez | 3 |
| TCR | 3 |
| Takanori | 3 |
| Takasaka | 3 |
| Taylor | 3 |
| Terminator | 3 |
| Tests | 3 |
| Therapeutics | 3 |
| Thoracic | 3 |
| Thromboembolic | 3 |
| Thrombosis | 3 |
| Tomoko | 3 |
| Town | 3 |
| Trade | 3 |
| Travel | 3 |
| Trials | 3 |
| UF | 3 |
| UNISDR | 3 |
| Universal | 3 |
| VP3 | 3 |
| VP4 | 3 |
| Validation | 3 |
| Validity | 3 |
| Venous | 3 |
| Version | 3 |
| Vienna | 3 |
| Surge | 3 |
| Surface | 3 |
| Support | 3 |
| Silveira | 3 |
| Senegal | 3 |
| Sepsis | 3 |
| Sequencing | 3 |
| Serologic | 3 |
| Services | 3 |
| Shan | 3 |
| Sheng | 3 |
| Sheri | 3 |
| Shinji | 3 |
| Ship | 3 |
| Sho | 3 |
| Short | 3 |
| Siegel | 3 |
| Somers | 3 |
| Supply | 3 |
| Sonia | 3 |
| Spearman | 3 |
| Specimens | 3 |
| St | 3 |
| StataCorp | 3 |
| Statement | 3 |
| Stringency | 3 |
| Stromal | 3 |
| Stubblefield | 3 |
| Studies | 3 |
| Su | 3 |
| Superantigens | 3 |
| Superspreading | 3 |
| Wai | 3 |
| Walker | 3 |
| Satoshi | 3 |
| Wangchuck | 3 |
| immunoassay | 3 |
| initiation | 3 |
| jrj | 3 |
| lymphohistiocytosis | 3 |
| mers | 3 |
| methylprednisolone | 3 |
| middle | 3 |
| ml | 3 |
| m∩w | 3 |
| nomograms | 3 |
| nucleocapsid | 3 |
| p=0.001 | 3 |
| pH | 3 |
| pandemic | 3 |
| pilgrim | 3 |
| singleplex | 3 |
| subgenomic | 3 |
| toxin-1 | 3 |
| type | 3 |
| upE | 3 |
| upper | 3 |
| ws | 3 |
| ys | 3 |
| Álvarez | 3 |
| Â10 | 3 |
| −1 | 3 |
| ≤0.5 | 3 |
| ☒ | 3 |
| Laser | 3 |
| icddr | 3 |
| hypomelanus | 3 |
| hyperinflammatory | 3 |
| Yun | 3 |
| Wardlaw | 3 |
| Website | 3 |
| Westmead | 3 |
| White | 3 |
| Williams | 3 |
| Wondfo | 3 |
| Workers | 3 |
| X | 3 |
| X13276 | 3 |
| Yamamoto | 3 |
| Yanhui | 3 |
| Youden | 3 |
| Yuki | 3 |
| ZIKV | 3 |
| human | 3 |
| Zegarelli | 3 |
| Zhijiang | 3 |
| Zhongshan | 3 |
| anterior | 3 |
| burnetii | 3 |
| camostat | 3 |
| chloroquine | 3 |
| cm | 3 |
| count | 3 |
| den | 3 |
| disease-2019 | 3 |
| exonic | 3 |
| group | 3 |
| Seeplex | 3 |
| Wen | 3 |
| Sara | 3 |
| Ontario | 3 |
| Megachiroptera | 3 |
| Member | 3 |
| Metropolitan | 3 |
| Michael | 3 |
| Mobility | 3 |
| Modelling | 3 |
| Mohammed | 3 |
| Monica | 3 |
| Morocco | 3 |
| Multidrug | 3 |
| Municipal | 3 |
| Muslims | 3 |
| Mycoplasma | 3 |
| nan | 3 |
| NC | 3 |
| NCD | 3 |
| NOS | 3 |
| Nanopore | 3 |
| Nelson | 3 |
| Next | 3 |
| Ningxia | 3 |
| Noh | 3 |
| Northeast | 3 |
| Ntoumi | 3 |
| Number | 3 |
| Nursing | 3 |
| OB | 3 |
| OVB | 3 |
| Omoleke | 3 |
| Meeting | 3 |
| Med | 3 |
| Masahiro | 3 |
| Luis | 3 |
| Lassa | 3 |
| Sanofi | 3 |
| Lauer | 3 |
| Laxminarayan | 3 |
| Leblebicioglu | 3 |
| Lei | 3 |
| Leuzinger | 3 |
| Level | 3 |
| Library | 3 |
| Limited | 3 |
| Lloyd | 3 |
| Local | 3 |
| Loss | 3 |
| Lyme | 3 |
| Mary | 3 |
| Lyssaviruses | 3 |
| MA | 3 |
| ML | 3 |
| MODS | 3 |
| Mai | 3 |
| Mainland | 3 |
| Major | 3 |
| Mandell | 3 |
| Manpower | 3 |
| Manuel | 3 |
| Map | 3 |
| Mar | 3 |
| Mark | 3 |
| Ong | 3 |
| Material | 3 |
| Organisation | 3 |
| Quality | 3 |
| RECOVERY | 3 |
| RR | 3 |
| Rabies | 3 |
| Raiwind | 3 |
| RdRp | 3 |
| Ready | 3 |
| Referral | 3 |
| Release | 3 |
| Rello | 3 |
| Renmin | 3 |
| Reproduction | 3 |
| Resistance | 3 |
| Rhinovirus | 3 |
| Rickettsia | 3 |
| River | 3 |
| Rochars | 3 |
| Rodriguez | 3 |
| Rodríguez | 3 |
| Romero | 3 |
| Rwanda | 3 |
| S3 | 3 |
| SEROCoV | 3 |
| SF | 3 |
| SM | 3 |
| Sabin | 3 |
| Sains | 3 |
| OxCGRT | 3 |
| Sample | 3 |
| Sanders | 3 |
| RCTs | 3 |
| Richardson | 3 |
| Paralympic | 3 |
| Pietro | 3 |
| PEEP | 3 |
| QIAamp | 3 |
| PANDORA | 3 |
| PH | 3 |
| PO | 3 |
| PRISMA | 3 |
| PRNT | 3 |
| PVL | 3 |
| Partnership | 3 |
| Pathogenic | 3 |
| Peiris | 3 |
| Performance | 3 |
| Picornaviridae | 3 |
| Personal | 3 |
| Postexposure | 3 |
| Prospective | 3 |
| Pilot | 3 |
| Pneumococcal | 3 |
| Po | 3 |
| Polymerase | 3 |
| Pooling | 3 |
| Positive | 3 |
| Pilgrims | 3 |
| Practices | 3 |
| Prism | 3 |
| Provinces | 3 |
| Programme | 3 |
| HPV | 2 |
| HL | 2 |
| HH | 2 |
| HKU1 | 2 |
| HIN1 | 2 |
| Haemostasis | 2 |
| HSV | 2 |
| González | 2 |
| Haenisch | 2 |
| Haj | 2 |
| Hall | 2 |
| Halyabar | 2 |
| Han | 2 |
| Hang | 2 |
| HCMV | 2 |
| Hanta | 2 |
| HCW | 2 |
| Grasselli | 2 |
| HBV | 2 |
| HA330II | 2 |
| H9N2 | 2 |
| H2 | 2 |
| Gómez | 2 |
| Gyeongsanggbuk | 2 |
| Guatemala | 2 |
| Guardian | 2 |
| Gu | 2 |
| Gong | 2 |
| Grosso | 2 |
| Gressier | 2 |
| Grande | 2 |
| Grabenstein | 2 |
| Harthy | 2 |
| Harnden | 2 |
| IFR | 2 |
| Hausfater | 2 |
| Hygiene | 2 |
| Howard | 2 |
| Hsueh | 2 |
| Hun | 2 |
| Hungary | 2 |
| Hurricane | 2 |
| Hydrogenii | 2 |
| Hébert | 2 |
| Hazlett | 2 |
| IDDM | 2 |
| IL)-6 | 2 |
| IL-1β | 2 |
| IL-7 | 2 |
| Giovanni | 2 |
| IL1 | 2 |
| Hospitalization | 2 |
| Horn | 2 |
| Horizon | 2 |
| Honduras | 2 |
| Hoffmann | 2 |
| Hodgins | 2 |
| Hitoshi | 2 |
| Histopathology | 2 |
| Hiroki | 2 |
| Highlights | 2 |
| Heywood | 2 |
| Henan | 2 |
| Hematology | 2 |
| Hematological | 2 |
| Helmholtz | 2 |
| Hefei | 2 |
| Heel | 2 |
| Goiania | 2 |
| Estimate | 2 |
| Giorgio | 2 |
| Federative | 2 |
| FTD | 2 |
| FU | 2 |
| Factor | 2 |
| Faculty | 2 |
| Faso | 2 |
| Fast | 2 |
| Federica | 2 |
| FIO2 | 2 |
| Feller | 2 |
| Ferraglia | 2 |
| Fig.1A | 2 |
| Fig.1A&1B | 2 |
| Fig.2 | 2 |
| Filoviridae | 2 |
| FMs | 2 |
| FIB | 2 |
| Gilbert | 2 |
| Española | 2 |
| IL6 | 2 |
| Epicontacts | 2 |
| Equipment | 2 |
| Era | 2 |
| Erythematosus | 2 |
| España | 2 |
| Estudio | 2 |
| Extraction | 2 |
| Etzioni | 2 |
| Eunha | 2 |
| Evidence | 2 |
| Evolution | 2 |
| Exchange | 2 |
| Experience | 2 |
| Finland | 2 |
| Fiore | 2 |
| Flasche | 2 |
| GeneXpert | 2 |
| GRID | 2 |
| GSOD | 2 |
| Gangelt | 2 |
| Garg | 2 |
| Gathering | 2 |
| Gatherings | 2 |
| Generalized | 2 |
| Flaxman | 2 |
| Geneviève | 2 |
| GeoDetector | 2 |
| George | 2 |
| Gerardo | 2 |
| German | 2 |
| Giacomelli | 2 |
| GPS | 2 |
| GGM | 2 |
| GCS | 2 |
| GAVO | 2 |
| GABRIEL | 2 |
| Future | 2 |
| Fusion | 2 |
| Fung | 2 |
| Fry | 2 |
| Frugivorous | 2 |
| Friedman | 2 |
| Fraser | 2 |
| Franklin | 2 |
| Francisella | 2 |
| Francis | 2 |
| Forster | 2 |
| Flora | 2 |
| IL10 | 2 |
| MSCs | 2 |
| INGOs | 2 |
| Lawrence | 2 |
| La | 2 |
| Laboratories | 2 |
| Lahore | 2 |
| Landguth | 2 |
| Laninamivir | 2 |
| Lau | 2 |
| Leaders | 2 |
| LOCF | 2 |
| Lechien | 2 |
| Legionnaires | 2 |
| Leng | 2 |
| Lessons | 2 |
| Letter | 2 |
| Leucocytosis | 2 |
| LT | 2 |
| LMICs | 2 |
| Khamis | 2 |
| Koreans | 2 |
| Killerby | 2 |
| Klugman | 2 |
| Kock | 2 |
| Kojima | 2 |
| Kolmogorov | 2 |
| Koo | 2 |
| Kowloon | 2 |
| Kılınc | 2 |
| Kreuder | 2 |
| Kritas | 2 |
| Kucharski | 2 |
| Kumar | 2 |
| Kusel | 2 |
| Kuwait | 2 |
| Leuven | 2 |
| Lianhua | 2 |
| Life | 2 |
| Machida | 2 |
| MR004 | 2 |
| Engine | 2 |
| MTB | 2 |
| MVA | 2 |
| MVD | 2 |
| Maani | 2 |
| Macrophage | 2 |
| Like | 2 |
| Madani | 2 |
| Madinah | 2 |
| Madjid | 2 |
| Madoff | 2 |
| Maggie | 2 |
| Magnetic | 2 |
| MB+CVD | 2 |
| MB | 2 |
| MAFFT | 2 |
| Luyt | 2 |
| Lusaka | 2 |
| Lucille | 2 |
| Lucey | 2 |
| Lucero | 2 |
| Lou | 2 |
| Lombardia | 2 |
| Lohse | 2 |
| Livzon | 2 |
| Literature | 2 |
| Linton | 2 |
| Linden | 2 |
| Lima | 2 |
| Likelihood | 2 |
| Khatun | 2 |
| Khalili | 2 |
| ISS | 2 |
| Investigator | 2 |
| InfluNet | 2 |
| Inhibitor | 2 |
| Initial | 2 |
| Initiation | 2 |
| Integrated | 2 |
| Internet | 2 |
| Involvement | 2 |
| Infectology | 2 |
| Ionization | 2 |
| Ip | 2 |
| Ireland | 2 |
| Irene | 2 |
| Islam | 2 |
| Istanbul | 2 |
| Infectología | 2 |
| Infect | 2 |
| Kempuraj | 2 |
| Il-6 | 2 |
| IVIG | 2 |
| Ibrahim | 2 |
| IgA | 2 |
| IgM. | 2 |
| Iha | 2 |
| Il | 2 |
| Illumina | 2 |
| Induction | 2 |
| Immunoassay | 2 |
| Immunomodulation | 2 |
| Importation | 2 |
| Income | 2 |
| Indicators | 2 |
| Indirect | 2 |
| JA | 2 |
| JAMA | 2 |
| JR | 2 |
| Kaleem | 2 |
| Jullien | 2 |
| Junichi | 2 |
| K.H. | 2 |
| KHGH | 2 |
| Kafrawy | 2 |
| Kaihuan | 2 |
| Kam | 2 |
| JSPS | 2 |
| Kappa | 2 |
| Karachi | 2 |
| Karim | 2 |
| Kato | 2 |
| Kazwala | 2 |
| Keisuke | 2 |
| Julien | 2 |
| José | 2 |
| Joska | 2 |
| Joseph | 2 |
| Joo | 2 |
| Jong | 2 |
| Jolla | 2 |
| Joinpoint | 2 |
| Johani | 2 |
| Jing | 2 |
| Jin | 2 |
| Jie | 2 |
| Jeong | 2 |
| Javier | 2 |
| Jang | 2 |
| Jaffar | 2 |
| Jae | 2 |
| Enze | 2 |
| Carmen | 2 |
| EndNote | 2 |
| Bayesian | 2 |
| Barbeschi | 2 |
| Barcelona | 2 |
| Bartlett | 2 |
| Bauch | 2 |
| Baxter | 2 |
| Bay | 2 |
| Behavioral | 2 |
| Bagnato | 2 |
| Beigel | 2 |
| Beldomenico | 2 |
| Belief | 2 |
| Berkley | 2 |
| Betacoronavirus | 2 |
| Betsch | 2 |
| Banerjee | 2 |
| BV | 2 |
| Articles | 2 |
| Authorization | 2 |
| Asmary | 2 |
| Assay | 2 |
| Assessing | 2 |
| Atmospheric | 2 |
| Australians | 2 |
| Authorities | 2 |
| Avaxim | 2 |
| BTV | 2 |
| Aziz | 2 |
| BC | 2 |
| BM | 2 |
| BSA | 2 |
| BSI | 2 |
| BSL-3 | 2 |
| Biancatelli | 2 |
| Bill | 2 |
| Biomedical | 2 |
| CINAHL | 2 |
| Burkina | 2 |
| Burrel | 2 |
| Buttrini | 2 |
| Bénet | 2 |
| CCDC | 2 |
| CHWs | 2 |
| CK | 2 |
| Biosafety | 2 |
| CLIA | 2 |
| CMAPs | 2 |
| CMV | 2 |
| CNIL | 2 |
| COVACTA | 2 |
| COVID-19)-7 | 2 |
| Burkholderia | 2 |
| Burden | 2 |
| Bulut | 2 |
| Bruel | 2 |
| Broad | 2 |
| Brealey | 2 |
| Brazzaville | 2 |
| Braunschweig | 2 |
| Bouvier | 2 |
| Boutolleau | 2 |
| Borba | 2 |
| Bogogiannidou | 2 |
| Bocavirus | 2 |
| Bo | 2 |
| Blueprint | 2 |
| Blood | 2 |
| Black | 2 |
| Asghar | 2 |
| Arita | 2 |
| Encephalitis | 2 |
| Adoption | 2 |
| Abdul | 2 |
| Abe | 2 |
| Achilles | 2 |
| Act | 2 |
| Action | 2 |
| Adolescents | 2 |
| Adriana | 2 |
| ARIMA | 2 |
| Adult | 2 |
| Advice | 2 |
| Aetiological | 2 |
| Agents | 2 |
| Agrati | 2 |
| Alan | 2 |
| AZ | 2 |
| AOR | 2 |
| Argentina | 2 |
| 8C | 2 |
| Main | 2 |
| -3 | 2 |
| 01q775up | 2 |
| 10Au | 2 |
| 229E/ | 2 |
| 5μg | 2 |
| 976qxja2 | 2 |
| ANPEP | 2 |
| A.A. | 2 |
| AA | 2 |
| ACIP | 2 |
| AGP | 2 |
| AIIR | 2 |
| ALK | 2 |
| Albert | 2 |
| Alex | 2 |
| Alexis | 2 |
| Annals | 2 |
| Andersen | 2 |
| Angiotensin | 2 |
| Anh | 2 |
| Animals | 2 |
| Anita | 2 |
| Anna | 2 |
| Anosmia | 2 |
| Alfonso | 2 |
| Anticoagulant | 2 |
| Antithrombotic | 2 |
| Antiviral | 2 |
| Apheresis | 2 |
| Appendix | 2 |
| Arcangeletti | 2 |
| Anantharajah | 2 |
| Analyzer | 2 |
| Analytics | 2 |
| Analyses | 2 |
| Ana | 2 |
| Amorim | 2 |
| Amna | 2 |
| Aminopeptidase | 2 |
| Amina | 2 |
| Ambient | 2 |
| Alzeer | 2 |
| Alzahrani | 2 |
| Alliance | 2 |
| Allergy | 2 |
| Allahabad | 2 |
| All | 2 |
| Alignment | 2 |
| COVID-19-associated | 2 |
| CPE | 2 |
| CPP | 2 |
| Diego | 2 |
| Desmodus | 2 |
| Desorption | 2 |
| Developing | 2 |
| Devex | 2 |
| Dhabi | 2 |
| Diaz | 2 |
| Dingmei | 2 |
| Design | 2 |
| Disinfection | 2 |
| Ditan | 2 |
| Doctor | 2 |
| Document | 2 |
| Données | 2 |
| Dres | 2 |
| Desjardins | 2 |
| Delivery | 2 |
| CRF01_AE | 2 |
| Dagan | 2 |
| DLM | 2 |
| DP | 2 |
| DPA | 2 |
| DQ | 2 |
| DR4 | 2 |
| DRC | 2 |
| Daiki | 2 |
| Decision | 2 |
| Daily | 2 |
| Damme | 2 |
| Daniel | 2 |
| Daozhou | 2 |
| Davidson | 2 |
| Davies | 2 |
| Drijkoningen | 2 |
| Driscoll | 2 |
| Drs | 2 |
| Elisa | 2 |
| Edward | 2 |
| Effective | 2 |
| Egyptian | 2 |
| Ehrlichia | 2 |
| Eidolon | 2 |
| Eikenberry | 2 |
| Ellen | 2 |
| Duc | 2 |
| Elmer | 2 |
| Embolism | 2 |
| Emergencies | 2 |
| Emily | 2 |
| Emmanuel | 2 |
| Empiric | 2 |
| Edouard | 2 |
| Editorial | 2 |
| Edition | 2 |
| Economy | 2 |
| EcoHealth | 2 |
| EViews | 2 |
| EUA | 2 |
| ESP | 2 |
| ESGITM | 2 |
| ESGCIP | 2 |
| EMBASE | 2 |
| EEA | 2 |
| EC(50 | 2 |
| EBV | 2 |
| E7 | 2 |
| Dushoff | 2 |
| Dufresne | 2 |
| DH | 2 |
| DENV-2 | 2 |
| Cytokines | 2 |
| Chezzi | 2 |
| Catteau | 2 |
| Challenger | 2 |
| Change | 2 |
| Charlotte | 2 |
| Chary | 2 |
| Chengdu | 2 |
| Chih | 2 |
| Clarke | 2 |
| Chile | 2 |
| Chimeric | 2 |
| Chlamydophila | 2 |
| Christian | 2 |
| Christine | 2 |
| Chun | 2 |
| Cathia | 2 |
| Cases | 2 |
| Cary | 2 |
| Carrat | 2 |
| Carolina | 2 |
| Carlo | 2 |
| Cape | 2 |
| Candelaria | 2 |
| Calvez | 2 |
| Calderaro | 2 |
| CYL | 2 |
| CXRs | 2 |
| CW | 2 |
| CVD | 2 |
| CTPA | 2 |
| CTC | 2 |
| CSL | 2 |
| Circulation | 2 |
| Classification | 2 |
| Current | 2 |
| Coxiella | 2 |
| Conto | 2 |
| Convention | 2 |
| Corchuelo | 2 |
| Cordoba | 2 |
| Covid19 | 2 |
| Cowling | 2 |
| Criteria | 2 |
| Cluster | 2 |
| Cruise | 2 |
| Cruises | 2 |
| Cryptococcus | 2 |
| Cui | 2 |
| Culture | 2 |
| Cunningham | 2 |
| Context | 2 |
| Containment | 2 |
| Confederation | 2 |
| Conclusions | 2 |
| Complex | 2 |
| Communication | 2 |
| Communicable | 2 |
| Commonwealth | 2 |
| Common | 2 |
| Commissions | 2 |
| Colunga | 2 |
| Collection | 2 |
| Cold | 2 |
| Coagulopathy | 2 |
| CoVs | 2 |
| CoVZXC21 | 2 |
| CoV)-update | 2 |
| Maharaj | 2 |
| Epidemics | 2 |
| Makoto | 2 |
| Vanhorebeek | 2 |
| Valencia | 2 |
| Valentine | 2 |
| Valle | 2 |
| Value | 2 |
| Valérie | 2 |
| Vanessa | 2 |
| Veneto | 2 |
| Vaccination | 2 |
| Verde | 2 |
| Viboud | 2 |
| Victoria | 2 |
| View | 2 |
| Virological | 2 |
| Vogels | 2 |
| Vaccinia | 2 |
| VP0 | 2 |
| Tu | 2 |
| USC | 2 |
| Tung | 2 |
| Turkestani | 2 |
| Twenty | 2 |
| 2 | |
| Typhi | 2 |
| URI | 2 |
| Udo | 2 |
| VCC | 2 |
| Universiti | 2 |
| Update | 2 |
| Updates | 2 |
| Ursula | 2 |
| Utilization | 2 |
| VAPP | 2 |
| Von | 2 |
| W | 2 |
| WS | 2 |
| Xiaoyu | 2 |
| X8 | 2 |
| XL | 2 |
| Xi | 2 |
| Xi'an | 2 |
| Xiang | 2 |
| Xiaoquan | 2 |
| Xinhua | 2 |
| WTO | 2 |
| Xiong | 2 |
| Y.S. | 2 |
| YH | 2 |
| Yacong | 2 |
| Yangon | 2 |
| Yao | 2 |
| WuHan | 2 |
| Woods | 2 |
| Wood | 2 |